换一批Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
第一作者：
Edward W B,Jeffes
第一单位：
Diagnostic and Molecular Health Care Group, Veterans Affairs Medical Center, Long Beach, CA 90822, USA.
作者：
医学主题词
血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脑肿瘤(Brain Neoplasms);癌症疫苗(Cancer Vaccines);细胞系, 肿瘤(Cell Line, Tumor);细胞, 培养的(Cells, Cultured);药物协同作用(Drug Synergism);内皮细胞(Endothelial Cells);女(雌)性(Female);神经胶质瘤(Glioma);生长抑制物(Growth Inhibitors);免疫组织化学(Immunohistochemistry);吲哚类(Indoles);注射, 腹腔内(Injections, Intraperitoneal);白细胞介素2(Interleukin-2);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);巨噬细胞集落刺激因子(Macrophage Colony-Stimulating Factor);磁共振成像(Magnetic Resonance Imaging);膜蛋白质类(Membrane Proteins);RNA, 信使(RNA, Messenger);大鼠(Rats);大鼠, 近交F344(Rats, Inbred F344);受体, 生长因子(Receptors, Growth Factor);脾(Spleen)
DOI
10.4049/jimmunol.174.5.2533
PMID
15728459
发布时间
2019-05-16
- 浏览14
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
